Trials / Conditions / Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma
Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma
5 registered clinical trials studyying Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumor NCT03925428 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lympho NCT03749018 | David Bond, MD | Phase 2 |
| Withdrawn | Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver NCT03217253 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas NCT03198026 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Active Not Recruiting | Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mant NCT02494700 | M.D. Anderson Cancer Center | Phase 2 |